Polybrominated diphenyl ethers (PBDEs) are used in large quantities as flame retardant additives. In a recent study, we have seen that neonatal exposure to some brominated flame retardants can cause permanent aberrations in spontaneous motor behavior that seem to worsen with age. In view of an increasing amount of PBDEs in mother's milk and in the environment, the present study was undertaken to investigate whether there is a critical and limited phase, during neonatal life, for induction of persistent neurotoxic effects of 2,2,4,4,5-pentaBDE (PBDE 99). Neonatal NMRI male mice were exposed on day 3, 10, or 19 to 8 mg 2,2,4,4,5-pentaBDE/kg body weight. Uptake and retention of 2,2,4,4,5-penta[ 14 C]BDE were studied in the mouse brain after exposure to 1.5 M becquerel (Bq) 2,2,4,4,5-penta[ 14 C]BDE /kg body weight (bw) on postnatal day 3, 10, or 19. Spontaneous motor behavior was observed in 4-month-old mice. Mice exposed to 2,2,4,4,5-pentaBDE on day 3 or 10 showed significantly impaired spontaneous motor behavior, whereas no effect was seen in mice exposed on day 19. Neonatal mice exposed to 2,2,4,4,5-penta[
Polybrominated diphenyl ethers (PBDEs) are used as additive flame retardants. PBDEs are a group of chemical substances with the chemical formula C 12 H( 0-9 )Br( 1-10 )O, the theoretical number of possible congeners 209, a low vapor pressure at room temperature, and a high lipophilicity; log K ow ranges between 4.28 and 9.9 (IPCS, 1994) . These characteristics are very similar to those of the polychlorinated biphenyls (PCBs) (IPCS, 1993) . Products that contain PBDEs are electrical appliances such as computers and television sets, textiles, building materials, and other objects (IPCS, 1994 ) that contribute to a significant worldwide industrial sector.
PBDEs are not fixed in the polymer product through chemical binding and can thus leak into the environment (Hutzinger et al., 1976; Hutzinger and Thoma, 1987) . Studies have shown that PBDEs are present in the global environment (de Boer et al., 1998; Johnson and Olson, 2001; Manchester-Neesvig et al., 2001; Strandberg et al., 2001) and that levels of PBDEs are increasing in the Swedish environment (Andersson and Blomkvist, 1981; Nylund et al., 1992; Sellström et al., 1993) . The most commonly found PBDEs in the environment are PBDE 47, PBDE 99, PBDE 100, and PBDE 153 (Darnerud et al., 2001) . A recent report has shown the presence of PBDEs in Swedish mother's milk and also an exponential increase in PBDEs since 1972, whereas PCBs are decreasing steadily (Meironyté et al., 1999) . The most commonly found PBDE congeners in human milk are 2,2Ј,4,4Ј-tetraBDE (PBDE 47) and 2,2Ј,4,4Ј,5-pentaBDE (PBDE 99) (Norén and Meironyté, 2000) . The concentrations of PBDEs are still lower than those for PCBs and DDT, about 80 times and 3 times, respectively (Meironyté et al., 1999; Norén and Meironyté, 2000) . Samples of human blood have also been shown to contain PBDEs (Klasson-Wehler et al., 1997) , including from workers in the electrical dismantling industry that show serum levels of PBDEs (Sjödin et al., 1999) . This indicates that humans are exposed to PBDEs both as infants and as adults.
In a recent study, we have shown that neonatal exposure to PBDEs on day 10 can induce persistent dysfunction in adult mice, manifested as deranged spontaneous behavior (Eriksson et al., 2001b) . Of three different flame retardants investigated, 2,2Ј,4,4Ј-tetraBDE (PBDE 47), 2,2Ј,4,4Ј,5-pentaBDE (PBDE 99), and tetrabromo-bis-phenol-A (TBBPA), both PBDE 47 and PBDE 99 caused developmental neurotoxic effects. The observed effects, i.e., altered spontaneous motor behavior and reduced habituation capabilities, were also seen to worsen with increasing age as they were more pronounced in 4-month-old mice compared to 2-month-old mice.
Exposure to low doses of persistent (nondegradable) and/or nonpersistent environmental agents during neonatal brain development in the mouse, has been shown to induce irreversible disruption in adult brain function (Eriksson, 1997) . The persistent environmental agents, DDT and PCBs, have been shown to induce persistent effects in the mouse only when they are administered during a critical phase of neonatal brain development (Eriksson, 1998; Eriksson et al., 1992 Eriksson et al., , 2001b . These disturbances are induced during the period of rapid brain growth (brain growth spurt, BGS; Davison and Dobbing, 1968) . During the BGS, the brain undergoes several fundamental phases, such as dendritic and axonal outgrowth and the establishment of neural connections (Davison and Dobbing, 1968; Kolb and Whishaw, 1989) . During this period, animals also acquire many new motor and sensory abilities (Bolles and Woods, 1964) and their spontaneous behavior peaks (Campbell et al., 1969) . The BGS is associated with numerous biochemical changes that transform the feto-neonatal brain into that of the mature adult (Coyle and Yamamura, 1976; Fiedler et al., 1987) . This is also a time during development when the synthesis of brain lipids reaches its maximum. A pronounced retention of lipophilic agents, such as DDT and PCBs (Eriksson, 1984; Eriksson and Darnerud, 1985) , has been seen in the neonatal mouse brain during the BGS. In mammals, the timing of the BGS in terms of onset and duration varies from species to species. In the human, it begins during the third trimester of pregnancy and continues throughout the first 2 years of life, whereas in the guinea pig it takes place in utero. In rodents, however, the BGS is neonatal, spanning the first 3-4 weeks of life, and reaches its peak around postnatal day 10.
With regard to our earlier observations of pronounced retention and developmental neurotoxic effects caused by DDT and PCBs, as well as the similarities between the PBDEs DDT, and PCBs in regard to chemical and physical properties, geographical distribution pattern, and occurrence in mother's milk, the present study was undertaken to ascertain whether there is a defined critical period during the BGS, in the neonatal mouse, when it is susceptible to the effects of 2,2Ј,4,4Ј,5-pentaBDE on the spontaneous motor behavior of the adult. In order to study whether the tissue distribution or a defined critical phase of brain development is the underlying cause for developmental effects, the uptake and retention of 2,2Ј,4,4Ј,5-pentaBDE in the neonatal mouse brain was conducted. (Marsh et al., 1999; Ö rn et al., 1996) . The purity of the compounds exceeded 98%. The substances were dissolved in a mixture of egg lecithin (Merck, Darmstadt, Germany) and peanut oil (Oleum arachidis) (1:10 w/w) and then sonicated together with water to yield a 20% (w:w) fat emulsion vehicle containing, respectively, 0.8 mg 2,2Ј,4,4Ј,5-pentaBDE/ml (1.4 mol/ml) and 150 kBq/ml. The use of a 20% fat emulsion vehicle was to give a more physiologically appropriate absorption and hence distribution (Keller and Yeary, 1980; Palin et al., 1982) .
MATERIALS AND METHODS

Chemicals
Pregnant NMRI mice were obtained from B&K, Sollentuna, Sweden and were housed individually in plastic cages in a room with an ambient temperature of 22°C and a 12/12-h cycle of light and dark. The animals were supplied with standardized pellet food (Lactamin, Stockholm, Sweden) and tap water ad libitum. The pregnant NMRI mice were checked for births two times daily (0800 and 1800 h). The day of birth was assigned day 0, and pups born during the night were assigned day 0 when checked at 0800 h. The size of the litters was adjusted to 10 -12 mice, within the first 48 h after birth, by the killing of excess pups. The litters contained pups of both sexes, and no separation with regard to sex was made in the preweanling mice. At the age of 4 -5 weeks, all females were sacrificed and the males were placed in groups of 4 -7, in a room for male mice only, and raised under the same conditions as detailed above.
In the behavioral study, 3-, 10-, and 19-day-old mice of both sexes were given 8 mg of 2,2Ј,4,4Ј,5-pentaBDE/kg bw (14 mol 2,2Ј,4,4Ј,5-pentaBDE/kg bw) via a metal gastric tube, as one single oral dose. Mice serving as controls received, in the same manner, 10 ml/kg bw of the 20% fat emulsion vehicle. The dose was selected in order to be comparable to earlier developmental neurotoxicity studies on PCBs (Eriksson, 1998) , and also is a dose known to cause effects on adult spontaneous motor behavior when given to 10-day-old mice (Eriksson et al., 2001b) . Each of the different age categories contained three to five litters.
In the retention study, five male offspring in each litter were given 1.5 M Bq 2,2Ј,4,4Ј,5-penta[
14 C]BDE/kg body weight (40.5 Ci/kg bw), as one single oral dose, via a metal gastric tube, at the age of 3, 10, or 19 days. A sixth male in each litter, which did not receive 14 C-labeled PBDE 99, was used as a background control. Each age category contained two litters.
Spontaneous behavior test.
Spontaneous behavior was tested in the male mice at the age of 4 months, as described by Eriksson et al. (1992) . The animals were tested between 0800 and 1200 h under the same ambient light and temperature as their housing conditions. A total of 10 mice were randomly picked from the three to five different litters in each treatment group. Motor activity was measured for a 60-min period, divided into three 20-min time intervals, in an automated device consisting of cages (40 ϫ 25 ϫ 15 cm) placed within two series of infrared beams (low and high level) (Rat-O-Matic, ADEA Elektronik AB, Uppsala, Sweden) (Fredriksson, 1994) . The cages were placed in individual soundproofed boxes with separate ventilation. Twelve devices were run simultaneously, allowing a balance between treatments:
• Locomotion. Counting took place when the mouse moved horizontally through the low level grid of infrared beams.
• Rearing. Movement in the vertical plane was registered at a rate of four counts per s, when a single high level beam was interrupted, i.e., the number of counts obtained was proportional to time spent rearing.
• Total activity. All types of vibration within the cage, i.e., those caused by mouse movements, shaking (tremors), and grooming was registered by a pickup (gramophone-like pickup mounted on a lever with a counterweight), connected to the test cage.
Radioactivity of 2,2,4,4,5-penta[
14 C]BDE measured in the neonatal mouse brain. Each of the two litters from the three different age categories was sacrificed by decapitation 24 h or 7 days, respectively, after administration. The skull was opened and the brain sectioned just behind the cerebellum. The brain samples were placed in preweighed vials and weighed and individually solubilized in 1.5 ml Biolute tissue solubilizer (Zinsser Analythic, UK) at 48°C for 24 h. After solubilization, 18.5 ml scintillation liquid (Aquasafe 300ϩ, Zinsser, UK) was added to each vial. The samples were adapted overnight before being counted in a scintillation analyzer (Packard Tri-Carb 1900 CA). Counting efficiency was approximately 90% and quench correction was made by the external standard method. Counts/min values not exceeding background ϩ 3͌background were excluded.
Statistical analysis. Body weight data from each age category was subjected to the Student's t-test, comparing controls vs. treated animals. Spontaneous behavior data were subjected to a split-plot ANOVA (analysis of variance), and pairwise testing between treated groups and their corresponding control groups was performed using a Tukey HSD (honestly significant difference) test (Kirk, 1968) . The amount of radioactivity of 2,2Ј,4,4Ј,5-penta[
14 C]BDE in neonatal brain at 24 h after administration, as per mille (‰) of that administered, was compared with that found 7 days after administration in the same age category, using Student's t-test.
RESULTS
There were no clinical signs of dysfunction in the 2,2Ј,4,4Ј,5-pentaBDE-treated mice at any time during the experimental period. The body weights (mean Ϯ SD) of the 3-, 10-, or 19-day-old animals did not differ significantly (p Ͼ 0.1); in 3-day-old mice (control, 2.24 Ϯ 0.30 g, PBDE 99-treated, 2.30 Ϯ 0.34 g), 10-day-old mice (control, 6.00 Ϯ 0.87 g, PBDE 99-treated, 5.97 Ϯ 0.81 g), and 19-day-old mice (control, 11.23 Ϯ 0.63 g, PBDE 99-treated, 11.39 Ϯ 0.71 g). Neither were there any significant (p Ͼ 0.1) differences in adult animals (4 months old) treated on day 3 (control, 47.59 Effects on spontaneous behavior in adult mice. The results from the spontaneous behavioral variables, locomotion, rearing, and total activity in 4-month-old male mice after exposure to a single oral dose of 8.0 mg 2,2Ј,4,4Ј,5-pentaBDE/kg bw at the age of 3, 10, or 19 days are shown in Figure 1 .
For the vehicle-treated and the 2,2Ј,4,4Ј,5-pentaBDE-treated mice of all three age categories, a difference in spontaneous motor behavior was observed over time. There were significant group ϫ period interactions [F 10, 108 ϭ 16.34, F 10, 108 ϭ 40.97, F 10, 108 ϭ 16.37] for locomotion, rearing, and total activity variables, respectively.
Mice receiving the vehicle at the age of either 3, 10, or 19 days showed a decrease in activity over time in response to the diminished novelty of the test chambers. This behavioral pattern in control animals is in agreement with earlier reports (Ahlbom et al., 1995; Eriksson et al., 1992 Eriksson et al., , 1998 Eriksson et al., , 2000 .
Pairwise testing between 2,2Ј,4,4Ј,5-pentaBDE-treated mice and the control mice revealed a significant difference in behavior (Fig. 1) . Mice neonatally exposed to 2,2Ј,4,4Ј,5-pentaBDE on day 3 showed significantly altered behavior in the three variables, locomotion, rearing, and total activity, compared with the controls. The locomotion variable was significantly increased (p Յ 0.01) during the last 20-min period (time 40 -60 min). The rearing variable was significantly decreased (p Յ 0.01) during the first 20-min period (time 0 -20 min) and a significant increase (p Յ 0.01) in the rearing variable was seen in the 2,2Ј,4,4Ј,5-pentaBDE-treated mice, as compared with the control animals, during the last 20-min period (time 40 -60 min). For the third variable, total activity, a significantly increased activity (p Յ 0.01) was evident during the last 20-min period (time 40 -60 min) in mice exposed to 2,2Ј,4,4Ј,5-pentaBDE at 3 days of age.
Mice neonatally exposed to 2,2Ј,4,4Ј,5-pentaBDE on day 10 exhibited significantly decreased activity (p Յ 0.01) for all three behavioral variables, locomotion, rearing, and total activity, compared with the control group, during the first 20-min interval of the 60-min period (time 0 -20 min). During the last FIG. 1. Spontaneous behavior of 4-month-old mice after neonatal exposure to 8 mg (14 mol) 2,2Ј,4,4Ј,5-pentaBDE/kg body weight as a single oral dose or 20% fat emulsion (control), on day 3, 10, or 19. The data were subjected to an ANOVA with split-plot design and there were significant group ' period interactions [F 10, 108 ϭ 16.34, F 10, 108 ϭ 40.97, F 10, 108 ϭ 16.37] for the variables, locomotion, rearing, and total activity, respectively. Pairwise testing between 2,2Ј,4,4Ј,5-pentaBDE-treated mice and the control mice in each age category was performed using Tukey HSD tests. The statistical difference between vehicle-treated (control) mice and 2,2Ј,4,4Ј,5-pentaBDE-treated mice is indicated by asterisks: *p Ͻ 0.05; **p Ͻ 0.01. The height of the bars represents the mean value Ϯ SD. 20-min period (time 40 -60 min), a significantly increased activity (p Յ 0.01), compared with the control group, was seen for all three behavioral variables.
In mice neonatally exposed to 2,2Ј,4,4Ј,5-pentaBDE on day 19 there were no changes concerning the three behavioral variables compared with controls, i.e. a decrease in activity in all variables was evident over the 60-min period observation.
Retention of 2,2Ј,4,4Ј,5-penta[ 14 C]BDE in mouse brain after 24 h and 7 days following an oral exposure on day 3, 10, or 19.
The amounts of radioactivity found in the brain 24 h and 7 days after administration are shown in Fig. 2 . The amount of radioactivity, given as ‰ of total amount administered, was between 3.7 and 5.1 ‰ in the three different age categories, 24 h after administration. Seven days after administration, radioactivity was still present in the brain, but the amount of radioactivity had significantly declined to between 1.3 and 2.8 ‰ of the administered dose.
DISCUSSION
In this study, the administration of 2,2Ј,4,4Ј,5-pentaBDE (8 mg /kg body weight) to mice on neonatal day 3, 10, or 19 only caused disturbances in the spontaneous motor behavior of the adult mice neonatally exposed on day 3 or 10. Furthermore, neonatal exposure to 2,2Ј,4,4Ј,5-penta[
14 C]BDE in mice on day 3, 10, or 19 showed that the substance is taken up and distributed in the body and that the 2,2Ј,4,4Ј,5-penta[ 14 C]BDE or its metabolites is present in the brain 24 h after exposure. 2,2Ј,4,4Ј,5-penta[ 14 C]BDE or its metabolites can still be detected in the brain 7 days after administration in all three age categories. The results also indicate that the presence of 2,2Ј,4,4Ј,5-pentaBDE during a sensitive period of brain development is responsible for the neurobehavioral disturbances. The spontaneous motor behavior data showed a disruption of habituation in adult mice neonatally exposed to 2,2Ј,4,4Ј,5-pentaBDE on day 3 or 10. Normal habituation, defined here as a decrease in the variables locomotion, rearing, and total activity, in response to the diminished novelty of the test chamber over a 60-minute test period, divided into three 20-min periods, was seen in the control mice, treated on neonatal day 3, 10, or 19 with the 20% fat emulsion vehicle. The mice treated neonatally with 2,2Ј,4,4Ј,5-pentaBDE on day 3 or 10 showed a deviation from the normal habituation. The most pronounced effect was seen in mice exposed to 2,2Ј,4,4Ј,5-pentaBDE on neonatal day 10. At the age of 4 months these mice displayed a significantly hypoactive behavior during the first 20 min of the 60-min period for all three spontaneous behavior variables, locomotion, rearing and total activity. They also showed hyperactive behavior for all three spontaneous behavior variables during the last 20 min of the 60-min period. This supports the earlier findings by Eriksson et al. (2001b) concerning developmental toxicity of brominated flame retardants. In that study, male mice (NMRI) exposed neonatally on day 10 to 0.8 or 12 mg 2,2Ј,4,4Ј,5-pentaBDE/kg body weight, as one single oral dose, showed differences in spontaneous behavior at 4 months of age. It is of particular interest to note that the dose used in the present study (8 mg 2,2Ј,4,4Ј,5-pentaBDE/kg body weight) caused a derangement in spontaneous behavior in 4-month-old mice that falls in between the disturbances earlier seen for the two doses, 0.8 and 12 mg 2,2Ј,4,4Ј,5-pentaBDE/kg body weight (Eriksson et al., 2001b) , when comparing the ratio between the activity of the last 20-min period (time 40 -60 min) and the activity of the first 20-min period (time 0 -20 min) for the total activity variable, where the ratio for 2,2Ј,4,4Ј,5-pentaBDE 0.8 mg ϭ 0.60; 8.0 mg ϭ 1.07; and 12 mg ϭ 1.38. Taken together, the present findings and the earlier observed effects on spontaneous motor behavior in mice neonatally exposed to 2,2Ј,4,4Ј,5-pentaBDE (Eriksson et al., 2001b) indicate a dose-dependent mode of action by 2,2Ј,4,4Ј,5-pentaBDE. These changes in spontaneous behavior are very similar to the changes seen after neonatal exposure to certain PCBs. Neonatal exposure in mice on day 10 to some ortho-substituted PCBs, such as 2,4,4Ј-trichlorobiphenyl (PCB 28), 2,2Ј,5,5Ј-tetrachlorobiphenyl (PCB 52), 2,2Ј,4,4Ј,5,5Ј-hexachlorobiphenyl (PCB 153), and some coplanar PCBs, 3, 3Ј, 4, 3, 3Ј, 4, 4Ј, , and 3,3Ј,4,4Ј,5,5Ј-hexachlorobiphenyl, has been shown to cause a hypoactive condition in spontaneous behavior during the first 20-min period, while toward the end of the 60-min period the mice became hyperactive (see Eriksson, 1998) . These effects were shown to be related to both dose response and time response. These dose-and time-related similarities in effects of PBDEs and PCBs indicate that PBDEs can constitute a new class of environmental agents that might be involved in the induction of a brain dysfunctional process induced at a time of rapid brain development in the neonatal mouse.
In the mice exposed to 2,2Ј,4,4Ј,5-pentaBDE on neonatal day 3, the spontaneous behavior was also altered, although the effects were not as pronounced as in the animals exposed on neonatal day 10. Significantly hypoactive behavior during the first 20 min was only seen for the rearing variable. However, significantly hyperactive behavior was observed during the last 20 min for all three variables (locomotion, rearing, and total activity). This behavioral response also shows striking similarities to the changes in spontaneous behavior seen after neonatal exposure to PCB 52 on day 3. The effect from exposure on day 3 has been explained by the pronounced retention of PCB 52 in the neonatal mouse brain (see Eriksson, 1998) . In mice given 14 C-labeled PCB 52 on day 3, the amount of PCB 52 present on day 10 was calculated to be sufficient to induce behavioral disturbances.
The amount of toxic agent present in the brain at different neonatal ages may vary. Previous studies have shown a pronounced retention of lipophilic chlorinated hydrocarbons or their metabolites (e.g. DDT, PCB 52, PCB 153, and chlorinated paraffins) in the brain when administered on neonatal day 10 (Eriksson, 1984 (Eriksson, , 1998 Eriksson and Darnerud, 1985) . The amount of 2,2Ј,4,4Ј,5-pentaBDE or its metabolites, seen after neonatal exposure in the three different age categories, is in the same range as seen for the PCBs and DDT, i.e. 3-5 ‰ of the administered dose (Eriksson, 1984 (Eriksson, , 1998 Eriksson and Darnerud, 1985) . Differences in the amounts of 2,2Ј,4,4Ј,5-pentaBDE present in the neonatal brain at the different neonatal ages do not appear to explain the different behavioral effects seen in adult mice exposed on day 3, 10, or 19. The amount of radioactivity was not higher in the brains of animals exposed on day 3 or 10, yet a disturbance is seen in the spontaneous behavior of animals exposed to 2,2Ј,4,4Ј,5-BDE on postnatal day 3 or 10 but not in animals exposed on postnatal day 19. The disturbances seen after exposure on day 3 may be attributable to the fact that the amount was enough to induce behavioral disturbances. The calculated amount present on day 10 was approximately 10.7 pmol/g brain. The corresponding calculation for mice exposed to 0.8 mg 2,2Ј,4,4Ј,5-pentaBDE/kg body weight on postnatal day 10 in the previous study by Eriksson and coworkers (2001b) revealed an amount of 7.2 pmol/g brain, which was enough to induce behavioral disturbances in adult mice. The similarities between 2,2Ј,4,4Ј,5-pentaBDE and PCBs regarding uptake and neurobehavioral effects are of special concern, not only for PBDE as a single agent, but also because of the possibility of additative or interactive effects between these persistent environmental agents and PCB. Human epidemiological studies suggest that perinatal exposure to PCBs may have developmental neurotoxic effects (Fein et al., 1984; Jacobson and Jacobson, 1996; Rogan et al., 1988) , and experimental studies in animals (mice, rats, monkeys) support findings that exposure to PCBs during development can cause long-term neurobehavioral alterations (Tilson et al., 1990; Tilson and Harry, 1994; Seegal, 1996) .
In conclusion, the present investigation has shown that exposure in the mouse to 2,2Ј,4,4Ј,5-pentaBDE during a defined critical phase of brain development can give rise to irreversible changes in adult brain function. It was also shown that 2,2Ј,4,4Ј,5-pentaBDE can be taken up and retained in the neonatal mouse brain. The amount of 2,2Ј,4,4Ј,5-pentaBDE administered is comparable, on a molar level, to the dose at which some PCBs are known to cause developmental behavioral effects (for ref. see Eriksson, 1998; Eriksson et al., 2001b) . Susceptibility to developing such irreversible disturbances during a limited phase of the BGS has earlier been reported for PCBs (Eriksson, 1998) , DDT (Eriksson et al., 1992) , nicotine (Eriksson et al., 2000) , and OPs (Ahlbom et al., 1995) . It is worth noting that these agents also affected the cholinergic transmitter system, which is one of the major transmitter systems that correlate closely with cognitive function (Drachman, 1977; Fibiger, 1992) . This calls for further investigations of PBDEs as developmental neurotoxic agents, since levels in breast milk (Meironyté et al., 1999; Norén and Meironyté, 2000) and in the environment are increasing (Strandberg et al., 2001) .
